RNA enzymes (ribozymes) as antiviral therapeutic agents.
about
A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1Gene discovery by ribozyme and siRNA libraries.Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cellsCell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield.Convergent evolution of twintron-like configurations: One is never enough.Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better.Negative electrospray ionization mass spectrometry of synthetic and chemically modified oligonucleotidesSelective cleavage of closely-related mRNAs by synthetic ribozymes.Chemical synthesis of RNA using fast oligonucleotide deprotection chemistry.Inhibition of gene expression with ribozymes.Antiviral ribozymes. New jobs for ancient molecules.Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.
P2860
Q24683706-CAEE42F6-4A50-487C-BDE9-92A814B5834AQ33217148-7F57AD6B-22F7-469F-AC32-F4B344F3BE9CQ33652811-D1EE156A-91A4-449F-9AA7-D6E08C3AE5BDQ33939807-5668EAF7-6CEF-4DAD-96AA-2DB2ADC0A761Q34232003-3987E541-EE79-4E64-9814-1A86AB374D8BQ35927080-946BDF18-1407-4EE5-8A18-D1A540C135D4Q36685877-D059E783-59E2-4383-8F92-C1103B6AF27DQ36791493-0D00DA90-104F-4BCE-BE1F-FED83BAE891AQ37571777-B4434F87-56A7-4C7B-B0C6-6C747D5E44C9Q40401361-48828812-2125-4F01-A4E0-AD0AA26D5C04Q40420267-F04B1363-DE9E-4183-990F-727F15921047Q40421127-DB4B4AAB-1A56-4046-917A-CFF3D6AAF3F5Q40451946-F56968FA-01F2-4652-9386-FC94569FAE71Q41609445-A0359D2B-549E-4581-A22E-EB736CA3D784Q45865707-670DAE89-4054-4AF8-BBA5-C95744DEC527
P2860
RNA enzymes (ribozymes) as antiviral therapeutic agents.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
RNA enzymes (ribozymes) as antiviral therapeutic agents.
@ast
RNA enzymes (ribozymes) as antiviral therapeutic agents.
@en
type
label
RNA enzymes (ribozymes) as antiviral therapeutic agents.
@ast
RNA enzymes (ribozymes) as antiviral therapeutic agents.
@en
prefLabel
RNA enzymes (ribozymes) as antiviral therapeutic agents.
@ast
RNA enzymes (ribozymes) as antiviral therapeutic agents.
@en
P1476
RNA enzymes (ribozymes) as antiviral therapeutic agents.
@en
P2093
P304
P356
10.1016/0167-7799(90)90169-X
P577
1990-07-01T00:00:00Z